A chemically engineered, stable oligomer mimic of amyloid β42 containing an oxime switch for fibril formation

Organic & Biomolecular Chemistry
Masashi YamamotoYouhei Sohma

Abstract

Toxic aggregation of monomeric amyloid β (Aβ) into oligomers followed by the formation of fibrils is a causative process in the pathogenesis of Alzheimer's disease. The mechanism for furnishing the toxicity of Aβ aggregates is elusive, however, mainly due to the transient, unstable properties of the oligomer states. Oligomer mimics stabilized by chemical protein engineering are potentially useful tools for elucidating the pathogenicity of Aβ aggregates. Here we report a stable Aβ oligomer mimic that is transformed into fibrils by a chemical stimulus, i.e., an oxime exchange reaction. A derivative of Aβ42[Met35(O)], compound 2, containing an oxime tether between residues 23 and 28 (a salt-bridge surrogate between Asp23 and Lys28 of the Aβ42 oligomer), rapidly and homogeneously formed stable, relatively large oligomers with preserved amyloid-like properties, such as the propensity to form β-sheets and toxicity. Chemical cleavage of the tether via an oxime exchange reaction induced transformation of the oligomers into the fibril state. These results demonstrate that the oxime bond formation/cleavage can switch the aggregation state of the mimic by functionally surrogating the salt-bridge of Aβ42. This novel system temporally disse...Continue Reading

References

Mar 1, 1995·Annals of Neurology·S G Younkin
Aug 28, 1999·The Journal of Biological Chemistry·D M WalshD B Teplow
Nov 14, 2000·Biopolymers·O MelnykH Gras-Masse
Aug 29, 2002·The Journal of Biological Chemistry·Liming HouMichael G Zagorski
Dec 20, 2002·Angewandte Chemie·Stuart J RowanJ Fraser Stoddart
Dec 25, 2002·The Journal of Biological Chemistry·W Blaine StineMary Jo LaDu
Apr 20, 2005·Biochemistry·Kimberly L SciarrettaStephen C Meredith
Jun 8, 2006·Annual Review of Biochemistry·Fabrizio Chiti, Christopher M Dobson
Sep 14, 2006·Chemical Reviews·Peter T CorbettSijbren Otto
Feb 17, 2009·Biochemistry·Liping YuEdward T Olejniczak
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kenjiro OnoDavid B Teplow
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Anders SandbergTorleif Härd
Jun 22, 2011·Chemical Communications : Chem Comm·Conor M HaneyW Seth Horne
May 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·James C StroudDavid Eisenberg
Sep 18, 2013·ACS Chemical Neuroscience·Man Hoang VietPhilippe Derreumaux
Dec 10, 2013·Journal of the American Chemical Society·Paolo ArosioSara Linse
Sep 27, 2014·Angewandte Chemie·Christofer LendelTorleif Härd
May 6, 2015·Journal of the American Chemical Society·Sudhakar ParthasarathyYoshitaka Ishii
May 6, 2015·Nature Structural & Molecular Biology·Yiling XiaoYoshitaka Ishii
May 6, 2015·Chemical Society Reviews·Nabarun RoyJean-Marie Lehn
Aug 5, 2015·Biochemistry·Ghiam YaminDavid B Teplow
Sep 15, 2015·Biochemical and Biophysical Research Communications·Kazuma MurakamiKazuhiro Irie
Jan 5, 2016·Chemical & Pharmaceutical Bulletin·Youhei Sohma
Jun 30, 2016·Journal of the American Chemical Society·Michael T ColvinRobert G Griffin
Jul 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Marielle Aulikki WältiRoland Riek
Dec 22, 2016·Journal of the American Chemical Society·Adam G KreutzerJames S Nowick
Sep 9, 2017·Science·Lothar GremerGunnar F Schröder

❮ Previous
Next ❯

Citations

Dec 1, 2018·Organic & Biomolecular Chemistry·Johanes K KasimMargaret A Brimble
Jan 27, 2022·Biochemistry·Sheng ZhangJames S Nowick

❮ Previous
Next ❯

Methods Mentioned

BETA
atomic force microscopy
AFM
electrophoresis
circular dichroism
dissection

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.